The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia

NCT05035589 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

INDIV

Sponsor class

Conditions

COVID-19 Pneumonia
ARDS

Interventions

DRUG: Tocilizumab

Sponsor

Sciberras, Stephen M.D.

Collaborators

[object Object]